Phase I Study of GW856553 (Losmapimod)
Clinical trial NCT01648192 · COMPLETED
Trial details
- NCT number
- NCT01648192
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-24
- Primary completion
- 2012-10-26
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.